Chat With AI About GLP-1 Medication (At Your Own Peril)
American usage of artificial intelligence and GLP-1 medications has skyrocketed since 2024. Both technologies have risks, including some that are invisible.
Mindfulness a Requirement for Quitting GLP-1s
GLP-1s may encourage more mindful eating. Quitting GLP-1 medications may also require a turn toward mindfulness, which can be difficult for people with eating addiction or disorders.
GLP-1 Effects on Psilocybin Mushrooms
Scientists investigate what happens when people use GLP-1s and psilocybin mushrooms together, offering insights into the brain’s reward system.
What Should We Call JFK’s Sex Addiction?
A new book discusses JFK’s sex addiction. What’s left out are the debates about what qualifies as a sex addiction, whether it is a legitimate condition, or even if the term is ethical to use.
Cancer Rates Linked to Alcohol Use Doubled Since 1990
A new study links alcohol use to an increased risk for colorectal, esophageal, breast, pancreatic, and prostate cancers. Less than half of American adults know the correlation between drinking and cancer.
Fentanyl Vaccine May Move to Human Trials
Chemists develop a vaccine that could enable the body’s immune system to identify fentanyl molecules, creating an internal “stop sign.”